Comparative acute effects of brimonidine 0.2% versus dorzolamide 2% combined with beta-blockers in glaucoma

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 238, Issue 4, 2000, Pages 302-305

  Centofanti, Marco ^a,b,c   Manni, Gianluca ^a   Gregori, Daniela ^a   Cocco, Francesco ^a   Lorenzano, Daniele ^a   Bucci, Massimo G ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; DORZOLAMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034026482     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170050356     Document Type: Article

References (12)

1. Burke J, Schwartz M (1996) Preclinical evaluation of brimonidine. Surv Ophthalmol 41 [Suppl 1]: S9-S18
2. Cantor LB, Burke J (1997) Drug evaluation. Pulmonary-allergy, dermatology, gastrointestinal and arthritis. Brimonidine. Exp Opin Invest Drugs 6: 1063-1083
3. Derick RJ, Robin AL, Walters TR, et al (1997) Brimonidine tartrate. A one-month dose response study. Ophthalmology 104: 131-136
4. nd edn. Mosby, St. Louis, pp 1425-1448
5. 2-adrenoreceptor agonist for glaucoma treatment. J Glaucoma 6: 250-8
6. 2 adrenoreceptor activity. Bioorg Med Chem Lett 37:832
7. Norlund JR, Pasquale LR, Robin AL, et al (1995) Comparison of the cardiovascular and pulmonary effects of brimonidine 0.20%, timolol 0.5% and betaxolol suspension 0.25%. Arch Ophthalmol 113: 77-83
8. Schuman SJ (1996) Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension. Surv Ophthalmol 41 [Suppl 1]: S27-S37
9. Strahlman E, Tipping R, Vogel R, et al (1995) A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol and betaxolol. Arch Ophthalmol 113: 1009-1016
10. Thylefors B, Négrel AD (1994) The global impact of glaucoma. Bull World Health Org 72: 323-326
11. Toris CB, Camras CB, Yablonski ME (1995) Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol 113: 1514-1
12. 2 -adrenoceptor agonist AGN 191103 and brimonidine. Invest Ophthalmol Vis Sci 37 [Suppl 3]: S114, abstract 540